Luminus Management LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Luminus Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$37.38 - $49.47 $10.7 Million - $14.2 Million	-287,105 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$39.79 - $67.01 $11.4 Million - $19.2 Million	287,105 New	287,105 $12.6 Million
Q1 2019 May 15, 2019	SELL	$34.52 - $53.29 $5.03 Million - $7.77 Million	-145,850 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$29.75 - $42.9 $4.34 Million - $6.26 Million	145,850 New	145,850 $5.39 Million

785K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.58B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Luminus Management LLC, based on Form 13F filings with the SEC.

Stay updated on Luminus Management LLC with notifications on news.